Clarion Managing Director & Founder, Bart Lombardi, to Moderate Panel at CBI’s Bio/Pharmaceutical Product Commercialization and Launch Roadmap in Boston, MA

Oct 17, 2019

BOSTON–(BUSINESS WIRE)–Clarion, a life sciences strategy and organizational consultancy, today announced that Managing Director and Founder, Bart Lombardi will moderate a panel at CBI’s 5th Annual Bio/Pharmaceutical Product Commercialization and Launch Roadmap on Evolving Go-To-Market Strategies for Successful New Product Launch in 2020 & Beyond. The panel, which will include senior pharmaceutical industry executives, will take place on Tuesday, October 29, 2019 at 10:30am at the DoubleTree Suites in Boston.

Bart Lombardi has over 20 years of experience in corporate and portfolio strategy, new product launches, commercialization strategy, indication prioritization, managed care strategy, and BD&L strategy. Working across the spectrum from emerging biotech to Fortune 100 companies, Lombardi and the Clarion team understand the challenges and opportunities afforded by the continuously evolving health system landscape and the value of working closely with leadership teams to deliver the promise of innovation.

About Clarion

Clarion is a life sciences strategy and organizational consultancy that works together with its clients to envision, craft, and enable growth through innovation and leadership. Across therapeutic categories, Clarion collaborates deeply with its clients to tackle their most complex cross-functional business challenges and decisions throughout the product and company lifecycle. With over 15 years of unparalleled experience in new product commercialization, Clarion partners with leaders in the biopharma industry to guide strategic decision-making necessary to launch a first asset or expand an existing portfolio. For more information, please visit

About CBI

CBI, an Informa business, is the health and life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries. CBI’s proprietary and intensive market research and product feasibility testing methodology has helped CBI deliver timely and first to market content driven conferences. For more information, please visit



Corporate Contact:
Alison Baldyga
+1 617-447-2246

Media Contact:
Lisa DeScenza
+1 978-395-5970 

See all Member News